Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy

Journal: Science Advances

Published: 2020-05-01

DOI: 10.1126/sciadv.aax7881

Affiliations: 5

Authors: 13

Go to article
Institutions Share
Department of Oncology, LIH, Luxembourg 0.42
Sprint Bioscience AB, Sweden 0.35
Cancer Center Karolinska (CCK), KI, Sweden 0.12
Abramson Cancer Center, Penn, United States of America (USA) 0.08
Centre Hospitalier de Luxembourg (CHL), Luxembourg 0.04